Charoentum相关文献与解析，生知库 | 链接生命科学的每一步

The Impact of the COVID-19 Pandemic on Diagnosis, Treatment, and Survival of Lung Cancer Patients in Thailand from 2019-2021

2019-2021年新冠肺炎疫情对泰国肺癌患者诊断、治疗和生存的影响

Charoentum, Chaiyut; Aksorn, Chawin; Chaiwipassatorn, Khemruthai; Siroros, Khwanchanok; Tiangtawat, Kittipich; Ketpueak, Thanika; Suksombooncharoen, Thatthan; Chewaskulyong, Busayamas

肺炎

Development of A Risk Assessment Model for Venous Thromboembolism among Patients with Cholangiocarcinoma

胆管癌患者静脉血栓栓塞风险评估模型的建立

期刊:Clinical and Applied Thrombosis-Hemostasis

影响因子:2

doi:10.1177/10760296261420226

Niprapan, Piangrawee; Phinyo, Phichayut; Lapisatepun, Worakitti; Charoentum, Chaiyut; Tantiworawit, Adisak; Punnachet, Teerachat; Hantrakun, Nonthakorn; Piriyakhuntorn, Pokpong; Hantrakool, Sasinee; Rattanathammethee, Thanawat; Rattarittamrong, Ekarat; Norasetthada, Lalita; Chai-Adisaksopha, Chatree

Machine learning-based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma

基于机器学习的cfDNA片段化分析结合自动化毛细管电泳技术用于肝细胞癌的早期检测

期刊:

影响因子:

doi:10.1038/s43856-026-01437-5

Udomruk, Sasimol; Sutthitthasakul, Songphon; Bunsermvicha, Nuttida; Pinyopornpanish, Kanokwan; Pruksakorn, Dumnoensun; Charoenkwan, Phasit; Yongpitakwattana, Petlada; Khounkaew, Kanlaya; Jaimalai, Thanapak; Duangsan, Treephum; Orrapin, Santhasiri; Moonmuang, Sutpirat; Noisagul, Pitiporn; Pasena, Arnat; Suksakit, Pathacha; Gamngoen, Ratikorn; Teeyakasem, Pimpisa; Charoentum, Chaiyut; Kongkarnka, Sarawut; Lapisatepun, Worakitti; Chaiyawat, Parunya

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]

对“泛亚洲版 ESMO 胆道癌患者诊断、治疗和随访临床实践指南”的更正：[ESMO Open 9 (2024) 103647]

期刊:ESMO Open

影响因子:8.3

doi:10.1016/j.esmoop.2024.104074

Chen, L-T; Vogel, A; Hsu, C; Chen, M-H; Fang, W; Pangarsa, E A; Sharma, A; Ikeda, M; Park, J O; Tan, C K; Regala, E; Tai, D; Tanasanvimon, S; Charoentum, C; Chee, C E; Lui, A; Sow, J; Oh, D-Y; Ueno, M; Ramaswamy, A; Jeo, W S; Zhou, J; Curigliano, G; Yoshino, T; Bai, L-Y; Pentheroudakis, G; Chiang, N-J; Cervantes, A; Chen, J-S; Ducreux, M

The efficacy of premedication with 10 mg versus 20 mg of intravenous dexamethasone for prevention of paclitaxel hypersensitivity reaction in low-risk gynecologic cancer patients: a non-inferiority, randomized controlled mono-institutional trial

一项非劣效性、随机对照、单中心试验，旨在比较静脉注射10 mg与20 mg地塞米松预防低危妇科癌症患者紫杉醇超敏反应的疗效。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-025-14769-7

Sa-Ngiamphorn, Nutthakarn; Suprasert, Prapaporn; Charoentum, Chaiyut

Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource Settings

在资源有限的环境下，探讨接受一线化疗的晚期非小细胞肺癌患者的预后因素和生存结果

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14020335

Chayangsu, Chawalit; Khorana, Jiraporn; Charoentum, Chaiyut; Sriuranpong, Virote; Patumanond, Jayanton; Tantraworasin, Apichat

Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma

来自 HIMALAYA III 期研究的患者报告结局：Tremelimumab 联合 Durvalumab 治疗不可切除肝细胞癌

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.23.01462

Sangro, Bruno; Galle, Peter R; Kelley, Robin Kate; Charoentum, Chaiyut; De Toni, Enrico N; Ostapenko, Yurii; Heo, Jeong; Cheng, Ann-Lii; Wilson Woods, Andrea; Gupta, Charu; Abraham, Jayne; McCoy, Carrie L; Patel, Nikunj; Negro, Alejandra; Vogel, Arndt; Abou-Alfa, Ghassan K

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer

泛亚洲版ESMO胆道癌诊断、治疗和随访临床实践指南

期刊:ESMO Open

影响因子:8.3

doi:10.1016/j.esmoop.2024.103647

Dietary Counseling Outcomes in Patients with Lung Cancer in an Upper-Middle-Income Country: An Open-Label Randomized Controlled Trial

在中高收入国家，饮食咨询对肺癌患者疗效的影响：一项开放标签随机对照试验

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm13175236

Chewaskulyong, Busyamas; Malairungsakul, Haritchanan; Buranapin, Supawan; Jesadaporn, Panas; Ketpueak, Thanika; Suksombooncharoen, Thatthan; Charoentum, Chaiyut

Propensity Score Analysis of Second-Line Chemotherapy Outcome in Advanced Biliary Tract Cancer

晚期胆道癌二线化疗疗效的倾向评分分析

The Impact of the COVID-19 Pandemic on Diagnosis, Treatment, and Survival of Lung Cancer Patients in Thailand from 2019-2021

2019-2021年新冠肺炎疫情对泰国肺癌患者诊断、治疗和生存的影响

Development of A Risk Assessment Model for Venous Thromboembolism among Patients with Cholangiocarcinoma

胆管癌患者静脉血栓栓塞风险评估模型的建立

Machine learning-based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma

基于机器学习的cfDNA片段化分析结合自动化毛细管电泳技术用于肝细胞癌的早期检测

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]

对“泛亚洲版 ESMO 胆道癌患者诊断、治疗和随访临床实践指南”的更正：[ESMO Open 9 (2024) 103647]

The efficacy of premedication with 10 mg versus 20 mg of intravenous dexamethasone for prevention of paclitaxel hypersensitivity reaction in low-risk gynecologic cancer patients: a non-inferiority, randomized controlled mono-institutional trial

一项非劣效性、随机对照、单中心试验，旨在比较静脉注射10 mg与20 mg地塞米松预防低危妇科癌症患者紫杉醇超敏反应的疗效。

Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource Settings

在资源有限的环境下，探讨接受一线化疗的晚期非小细胞肺癌患者的预后因素和生存结果

Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma

来自 HIMALAYA III 期研究的患者报告结局：Tremelimumab 联合 Durvalumab 治疗不可切除肝细胞癌

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer

泛亚洲版ESMO胆道癌诊断、治疗和随访临床实践指南

Dietary Counseling Outcomes in Patients with Lung Cancer in an Upper-Middle-Income Country: An Open-Label Randomized Controlled Trial

在中高收入国家，饮食咨询对肺癌患者疗效的影响：一项开放标签随机对照试验